JPMorgan Chase & Co’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-100,728
| Closed | -$14.1M | – | 5111 |
|
|
2018
Q4 | $14.1M | Sell |
100,728
-68,180
| -40% | -$9.55M | ﹤0.01% | 1469 |
|
|
2018
Q3 | $28.9M | Buy |
168,908
+112,366
| +199% | +$19.2M | 0.01% | 1208 |
|
|
2018
Q2 | $9.81M | Sell |
56,542
-831
| -1% | -$144K | ﹤0.01% | 1834 |
|
|
2018
Q1 | $6.62M | Sell |
57,373
-8,058
| -12% | -$930K | ﹤0.01% | 2023 |
|
|
2017
Q4 | $5.51M | Buy |
65,431
+57,231
| +698% | +$4.82M | ﹤0.01% | 2192 |
|
|
2017
Q3 | $763K | Sell |
8,200
-46,600
| -85% | -$4.34M | ﹤0.01% | 3041 |
|
|
2017
Q2 | $4.4M | Buy |
54,800
+2,400
| +5% | +$192K | ﹤0.01% | 2193 |
|
|
2017
Q1 | $2.21M | Sell |
52,400
-43,604
| -45% | -$1.83M | ﹤0.01% | 2553 |
|
|
2016
Q4 | $3.08M | Buy |
96,004
+19,137
| +25% | +$615K | ﹤0.01% | 2444 |
|
|
2016
Q3 | $2.01M | Buy |
76,867
+14,006
| +22% | +$367K | ﹤0.01% | 2465 |
|
|
2016
Q2 | $1.46M | Buy |
62,861
+62,146
| +8,692% | +$1.44M | ﹤0.01% | 2588 |
|
|
2016
Q1 | $20K | Buy |
715
+191
| +36% | +$5.34K | ﹤0.01% | 3605 |
|
|
2015
Q4 | $15K | Buy |
+524
| New | +$15K | ﹤0.01% | 3552 |
|
|
2015
Q3 | – | Sell |
-166,000
| Closed | -$2.99M | – | 3509 |
|
|
2015
Q2 | $2.99M | Buy |
+166,000
| New | +$2.99M | ﹤0.01% | 2327 |
|